Chronic obstructive pulmonary disease (COPD) is more than "cough and breathlessness." How much the disease actually limits you — and how high your risk is for a serious flare — can be measured. That is the job of the COPD assessment: three validated tools, one clean assignment to GOLD group A, B, or E.
This guide walks through mMRC, CAT, and exacerbation history, how GOLD 2023 derives the group, and what it means for therapy.
Three tools, one verdict
GOLD (Global Initiative for Chronic Obstructive Lung Disease) recommends combining three validated instruments:
- mMRC (modified Medical Research Council scale) — dyspnea grade 0 to 4 (Bestall, Thorax 1999).
- CAT (COPD Assessment Test) — 8 items × 0–5 each, total 0–40 (Jones, Eur Respir J 2009).
- Exacerbations in the last 12 months — moderate count + hospitalizations.
mMRC — the dyspnea scale
| Grade | Description |
|---|---|
| 0 | Breathless only with strenuous exercise |
| 1 | Hurrying or walking up a slight hill |
| 2 | Walks slower than peers, has to stop |
| 3 | Stops after 100 m or after a few minutes |
| 4 | Too breathless to leave home or to dress |
The threshold for "many symptoms" is mMRC ≥ 2. It separates GOLD A from B (in patients at low exacerbation risk).
CAT — the symptom score
CAT covers eight domains: cough, phlegm, chest tightness, breathlessness on exertion, activities at home, confidence leaving home, sleep, and energy. Each item is rated 0–5, total 0–40:
| CAT score | Impact |
|---|---|
| < 10 | Low |
| 10 – 20 | Medium |
| 21 – 30 | High |
| 31 – 40 | Very high |
Clinically meaningful change: ≥ 2 points (MCID, Kon et al., Lancet Respir Med 2014). The GOLD threshold for "many symptoms" is CAT ≥ 10.
Exacerbations — the risk driver
An exacerbation is an acute worsening that triggers a treatment change:
- Moderate: outpatient — antibiotics and/or oral steroids.
- Severe: hospital admission or emergency-department visit.
GOLD assigns anyone with ≥ 2 moderate or ≥ 1 hospitalized exacerbation per year directly to group E — irrespective of symptoms.
The GOLD ABE matrix
| Group | Criteria | Initial therapy (cue) |
|---|---|---|
| A | 0–1 moderate, no admission · mMRC ≤ 1 · CAT < 10 | Single bronchodilator (LAMA or LABA) |
| B | 0–1 moderate, no admission · mMRC ≥ 2 or CAT ≥ 10 | LABA + LAMA (dual bronchodilation) |
| E | ≥ 2 moderate or ≥ 1 hospitalization | LABA + LAMA, ± ICS if eosinophils elevated |
Note: GOLD 2023 merged the previous groups C and D into a single group E. The rationale — exacerbation risk drives escalation independent of the symptom profile.
What the assessment does not replace
A COPD diagnosis requires post-bronchodilator FEV1/FVC < 0.70. The spirometric GOLD grade (1–4) hinges on FEV1 % predicted — that needs your clinician.
Symptom assessment and spirometry complement each other. A reassuring mMRC with a low FEV1 — or a high CAT with only mildly reduced FEV1 — each tell distinct stories.
What you can do now
- Quit smoking: the single most impactful intervention. Cuts exacerbation rate, FEV1 decline, and mortality.
- Check inhaler technique: up to 70% of COPD patients inhale incorrectly — a 2-minute pharmacy or clinic check fixes most errors.
- Pulmonary rehabilitation: measurable gains in exercise tolerance, CAT score, and quality of life (Cochrane 2023).
- Vaccinations: influenza, pneumococcus, COVID-19, RSV — fewer exacerbations.
Related topics & calculators
- Asthma control: COPD and asthma overlap (ACOS); patients with both should track each tool. See the ACT guide.
- VO₂max: maximal oxygen uptake correlates with CAT and is a strong outcome marker. See the VO₂max guide.
- Smoking cost: tobacco smoke is the leading cause. Visualizing the financial savings is a strong motivator. See the smoking cost calculator.
Run your COPD assessment now
10 questions, anonymous, instant. mMRC, CAT, and GOLD group (A/B/E) at a glance.
Open the COPD Assessment Calculator →Frequently asked questions
Is the assessment enough to diagnose COPD?
No. Diagnosis requires post-bronchodilator spirometry showing FEV1/FVC < 0.70. The assessment quantifies symptoms and risk in established COPD or signals when further work-up is warranted.
How often should I repeat the scales?
Every 6–12 months when stable. Sooner with any therapy change, after an exacerbation, or when you feel worse. The trend matters more than any single value.
What changed between ABCD (old) and ABE (new)?
Until 2022 GOLD used four groups (A, B, C, D). GOLD 2023 merged C and D into a single group E ("exacerbation"); high-risk patients are escalated regardless of symptom profile.
What does a CAT of 25 mean?
25 sits in the "high impact" band — many symptoms, considerable quality-of-life burden. That argues for a therapy review: dual bronchodilation, rehab, and ICS-eligibility discussion with a pulmonologist.